• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Surescripts Expands Medication Management for Adherence Solution

by HITC Staff 11/30/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Surescripts is expanding its medication management services to help providers address problems with a patient’s adherence to their medication regimen—a dangerous and costly issue for both patients and the healthcare system as a whole. Surescripts’ Medication Management for Adherence solution delivers real-time messages and alerts directly into the provider’s EHR software during the patient visit. Now, more than 6,300 care providers using software from Agastha, Aprima Medical Software, MedConnect, and PrognoCIS will have near real-time data and insights about how a patient is doing on his or her medication regimen, enabling more meaningful provider-patient interactions.

Surescripts’ Medication Management for Adherence solution provides closed-loop feedback and collaboration between care providers and payers, and is optimized in their EHR workflow for the physician to use during the patient visit. The solution intelligently manages adherence messages by discarding expired content or messages that have been resolved, so care providers see only relevant content that requires their attention.

“Medication non-adherence takes a huge toll on the patient’s wellbeing, as well as the cost of care. But physicians can only address the issue if they are armed with the correct information when it matters most–during the patient’s visit,” said Tom Skelton, Chief Executive Officer of Surescripts. “Our network’s unrivaled connectivity revolutionizes the use of valuable insights from payers, combined with innovative EHR technologies that enhance patient outcomes, giving physicians a digital snapshot of whether or not their patients are adhering to their medication, so that they can intervene when needed.”

The Centers for Disease Control and Prevention (CDC) calls medication non-adherence a national epidemic, costing the nation’s healthcare system $300 billion annually. Fifty percent of patients never take their medication as prescribed,2 which can negatively impact health outcomes and increase healthcare costs.

“Medication adherence is vital to helping providers improve patient care, especially those with chronic conditions. The direct integration of Surescripts’ Medication Management within the MedConnect product suite ensures providers can easily access this information,” explained Jimmy Chapman, President and CEO of MedConnect. “Our company is honored to be among the early adopters to connect with Surescripts to integrate this valuable service, and physician feedback has already been overwhelmingly positive.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Medication Adherance, Medication Adherence, Surescripts

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |